American Healthcare REIT, Inc. (AHR)

Real Estate Investment Trusts · market cap $9.0B · as of 2026-07-11

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

None scheduled

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

American Healthcare REIT, Inc. (AHR) is a real estate investment trust focused on healthcare properties, operating with approximately 192.7 million shares outstanding and a market cap of roughly $10.5 billion. The company has grown revenues steadily from $1.1 billion in 2021 to $2.3 billion in 2025, turning its first reported net profit of $70 million in 2025 after years of losses. There are no near-term binary catalysts identified; the thesis is purely an operational and income story.

The catalyst path

No upcoming catalysts in our calendar.

Pipeline

No pipeline data.

Price & technical context

3-month

+3.8%

6-month

+4.1%

12-month

+36.8%

52-wk range

$35.70–$53.19

vs 50-day MA

+2.0%

vs 200-day MA

+4.9%

Realized vol

24.1%

Max drawdown

-14.1%

Daily closes through 2026-06-24. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data

SEC filings — EDGAR filings for AHR (10-K, 10-Q, S-3, 13D/G, Form 4)
Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.